Searched for
SEROQUEL
Sun Pharma Q4 PAT seen 12% up at Rs 922 croreIt is likely to report a net profit of Rs 922 crore for quarter ended March 2013, up 12 per cent, as compared to a net profit of Rs 820 cro...27 May, 2013, 05.06 PM IST- Lupin’s numbers are below expectations: Ranjit Kapadia, Centrum BrokingIn an interview with ET Now, Ranjit Kapadia, Sr VP Institutional Research, Centrum Broking Pvt Ltd, gives his views on Lupin’s Q2 earnings....23 Oct, 2012, 04.50 PM IST
- Preview: Lupin PAT seen up 4% YoY; higher input cost to dent marginsAccording to ET NOW, domestic formulations business is likely to grow by 20-23 per cent while the exports may see growth of 35 per cent. Hi...22 Oct, 2012, 05.07 PM IST
- Brokerages maintain 'hold' on Dr Reddy's post resultsShares of Dr Reddy’s Laboratories (DRL) were down on profit booking after the company disappointed the street with its quarterly results ye...20 Jul, 2012, 01.30 PM IST
- Why Dr Reddy's labs is going to report good resultsThe Hyderabad-based company with FY12 net sales Rs 9674 crore is expected to report good results to the cheer of its investors.13 Jul, 2012, 03.39 PM IST
- Indian drug outlook favourable: ICRA & Moody'sAccording to the report, domestic formulation market size stood at Rs 58,300 crore, ranked third in terms of volume and tenth in terms of v...20 Jun, 2012, 06.52 PM IST
- Lupin Q4 net profit seen up 16% at Rs 263 croreLupin is expected to report a 16 percent YoY increase in its fourth quarter net profit at Rs 263 crore from Rs 227 crore in the year-ago pe...10 May, 2012, 10.46 AM IST
- Lupin, Dr Reddy's, Sun Pharma get USFDA nod for mental disorder drugThree drug majors, Lupin, Dr Reddy's, Sun Pharma have got approvals from the US health regulator to sell generic quetiapine fumarate tablet...28 Mar, 2012, 01.59 PM IST
- Dealing Room Buzz: Alstom, DRL, Raymond, TitanET Now spoke to dealers on institutional and high networth investors’ activity in the dealing room. Following stocks were on their radar on...28 Mar, 2012, 11.22 AM IST
- AstraZeneca Q3 net profit down 27 per centAstraZeneca PLC has reported a 27 per cent drop in third-quarter profit as it took nearly half a billion dollars in charges for product lia...28 Oct, 2010, 12.51 PM IST
- Pharmac to fully fund Dr Reddy's brand of QuetiapinePharmac, a New Zealand Government drug funder, will fully fund a brand of Quetiapine drug made by Indian firm Dr Reddy's Laboratories.30 Aug, 2010, 03.27 PM IST
- AstraZeneca first-quarter profit up 42 pcAstraZeneca posted a 42 per cent rise in first quarter net profit on Thursday, boosted by sales of its heart drug Toprol-XL in the United S...30 Apr, 2009, 09.57 PM IST
- Pharmaland: sometimes it’s all in the nameIndia will have to get its entire healthcare and pharma sector regulatory structure in place08 Sep, 2008, 12.00 AM IST
- Children's disorders increases sales of US pharma cosSales for children of antipsychotic medicines have exploded, fuelled by a 40-fold increase over nine years in the number of children diagno...07 Sep, 2007, 02.08 AM IST
- AstraZeneca plans to double job cutsAstraZeneca PLC said it will more than double previously planned job cuts as it revealed Thursday that quarterly profit fell 12.5 per cent.26 Jul, 2007, 05.32 PM IST
Load More
